Submit RFP

Meet us at AASLD, booth \#1861 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to pati...

As clinical development becomes more complex and data-driven, operating models need to evolve to support faster, more confident decision-making. This latest blog explores how FSP, FSO and hybrid approaches can be aligned...

Keeping patients engaged across multi-year follow-ups presents a serious hurdle for non-oncology immunotherapy trials. Read our whitepaper to discover how sponsors can curb attrition and support long-term safety monitori...

Emerging approaches to first-in-human studies are helping sponsors obtain meaningful clinical insights sooner through integrated study designs, stronger patient engagement, and strategic biomarker implementation. In thi...

A cross-functional challenge JCA introduces a common scientific assessment, but evidence expectations can span different populations, comparators, outcomes and national standards of care. A joined-up, cross-functional st...

Product arrival isn’t the same as treatment readiness. Before a patient can dose in a cell or gene therapy study, teams may need to verify identity, custody, release, product condition, timing and site readiness. If one ...

This year at #ISPOREurope2026, ICON and Mapi Research Trust are contributing research across a broad range of evidence-generation topics, from clinical outcome assessments and quality-of-life measures to AI-enabled analy...

Heading to #OCTDACH? Visit ICON at booth \#6. Our team will be on-site to discuss the trends, challenges, and opportunities shaping the future of clinical research and digital health. Whether you're looking to optimise ...

Early-intervention therapies for chronic disease are a promising but technically demanding opportunity in drug development. In this whitepaper, experts across chronic disease indications explain how to leverage biomarker...

Spend less time managing the publishing process. PubsHub PMSolution offers all of the features you need to address the challenges of scientific publishing. Discover how PMSolution will help your team improve their effici...

We're looking forward to seeing you at #OCTDACH tomorrow in Basel. Join the ICON team at booth \#6 and discover how we're helping sponsors navigate complexity, accelerate trial delivery, and bring therapies to patients ...

As competition intensifies, biosimilar developers must look beyond traditional approaches and prepare for more complex molecules, tighter timelines and global market dynamics. Forward-thinking strategies can help program...